To include your compound in the COVID-19 Resource Center, submit it here.

Chiasma closes $70M series E round

Chiasma Inc. (Jerusalem, Israel) closed an oversubscribed $70 million series E

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE